Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192 This European Standard supersedes BS

This European Standard supersedes BS EN 50016:2002 which will be withdrawn in June 2007

Medical institutions and organisations

and those manufactured from other isotropic

terms and conditions of employment

based on high performance liquid chromatography (HPLC)

Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192 This European Standard supersedes BSWhat is this standard about? This document provides guidance for ancillary material (AM) users. It is applicable to cellular therapeutic products, including those gene therapy products whereby cells form part of the final product. It does not apply to products without cells. This document focuses primarily on ancillary materials (AMs) of biological (human and animal) origin and their potential impurities and contaminants. NOTE 1 The decision chart in